Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The technology, developed by Katalin Karikó and Drew Weissman, also holds promise for HIV vaccines and cancer treatment.
Moderna and Merck’s customized neoantigen vaccine plus Keytruda lowered the risk for metastasis or death by 65%.
Moderna and Merck’s personalized neoantigen vaccine plus checkpoint inhibitor lowered the risk of disease progression after surgery by 44%.
A personalized cancer vaccine plus Keytuda lowered the risk of melanoma coming back after surgery.
The early cancer is detected, the easier it is to treat.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.